Gene · 1361
Papers2,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Deep Sea Isoindole Alkaloid FGFC1 Exhibits Its Fibrinolytic Effects by Inhibiting Thrombin-Activatable Fibrinolysis Inhibitor. | Pharmaceuticals (Basel) | 2024 | 39459040 | PubTator, text mining | PubMed |
| Trypsin Digestion Conditions of Human Plasma for Observation of Peptides and Proteins from Tandem Mass Spectrometry. | ACS Omega | 2024 | 39398168 | PubTator, text mining | PubMed |
| Regulatory Effects of SLC7A2-CPB2 on Lymphangiogenesis: A New Approach to Suppress Lymphatic Metastasis in HNSCC. | Cancer Med | 2024 | 39382373 | PubTator, text mining | PubMed |
| High-dose atorvastatin and rosuvastatin reduce the levels of neutrophil extracellular trap-related proteins in coronary artery disease: association with prothrombotic state. | Pol Arch Intern Med | 2024 | 39324258 | PubTator, text mining | PubMed |
| Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach. | Circulation | 2024 | 39250537 | PubTator, text mining | PubMed |
| Plasmin generation analysis in patients with bleeding disorder of unknown cause. | Blood Adv | 2024 | 39231312 | PubTator, text mining | PubMed |
| Fibrinolysis is impaired in patients with primary immune thrombocytopenia. | J Thromb Haemost | 2024 | 39214313 | PubTator, text mining | PubMed |
| Antitumor Effects and the Potential Mechanism of 10-HDA against SU-DHL-2 Cells. | Pharmaceuticals (Basel) | 2024 | 39204193 | PubTator, text mining | PubMed |
| Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time. | Res Pract Thromb Haemost | 2024 | 39026660 | PubTator, text mining | PubMed |
| Angiogenesis outcomes of metformin utilization in diabetes mellitus: a systematic review and meta-analysis. | J Pak Med Assoc | 2024 | 39018137 | PubTator, text mining | PubMed |
| Identification of heparin interaction sites on thrombin-activatable fibrinolysis inhibitor that modulate plasmin-mediated activation, thermal stability, and antifibrinolytic potential. | Res Pract Thromb Haemost | 2024 | 38983903 | PubTator, text mining | PubMed |
| Reduced protein carbonylation on hormone therapy is associated with improved fibrinolysis in postmenopausal women: the impact of PAI-1 and TAFI activity. | J Thromb Thrombolysis | 2024 | 38981979 | PubTator, text mining | PubMed |
| Elevated plasma factor XI is associated with postthrombotic syndrome. | Thromb Res | 2024 | 38968817 | PubTator, text mining | PubMed |
| Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state. | J Thromb Thrombolysis | 2024 | 38965130 | PubTator, text mining | PubMed |
| On the Analysis of Inter-Relationship between Auto-Scaling Policy and QoS of FaaS Workloads. | Sensors (Basel) | 2024 | 38931559 | PubTator, text mining | PubMed |
| Knockout Genes in Bowel Anastomoses: A Systematic Review of Literature Outcomes. | J Pers Med | 2024 | 38929776 | PubTator, text mining | PubMed |
| Developing a Predictive Model for Metastatic Potential in Pancreatic Neuroendocrine Tumor. | J Clin Endocrinol Metab | 2024 | 38817124 | PubTator, text mining | PubMed |
| Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke. | Minerva Med | 2024 | 38727704 | PubTator, text mining | PubMed |
| RNA therapeutics to control fibrinolysis: review on applications in biology and medicine. | J Thromb Haemost | 2024 | 38663489 | PubTator, text mining | PubMed |
| Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives. | J Clin Med | 2024 | 38610717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1361/papers?page=4